Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biofrontera Inc
(NQ:
BFRI
)
1.210
UNCHANGED
Streaming Delayed Price
Updated: 3:57 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biofrontera Inc
< Previous
1
2
3
Next >
Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz(R)-PDT
June 01, 2023
Via
ACCESSWIRE
Biofrontera Inc. Names Founder and Executive Chairman Hermann Luebbert as Chief Executive Officer
May 30, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces U.S. Patent Issued for Photodynamic Therapy Protocol with Reduced Side Effects
May 15, 2023
Via
ACCESSWIRE
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
May 12, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Resignation of CEO
May 12, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces New Secured Line of Credit up to $6.5 Million
May 11, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting
March 17, 2023
Via
ACCESSWIRE
Biofrontera Collaborates with The Skin Cancer Foundation to Raise Awareness of Skin Cancer Prevention
May 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Report First Quarter 2023 Financial Results on May 12, 2023
April 28, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz(R)
April 26, 2023
Via
ACCESSWIRE
Biofrontera Inc. Makes Transformative Investment in Its' Dermatology Salesforce
March 27, 2023
Via
ACCESSWIRE
CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
March 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
March 08, 2023
Via
ACCESSWIRE
Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023
March 02, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
February 22, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
January 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022
January 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference
November 30, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
November 28, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
November 21, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 14, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
November 10, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
November 08, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
October 31, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
October 24, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
October 20, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference
October 18, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan
October 14, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022
October 12, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
October 05, 2022
From
Biofrontera Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.